LXEO
Lexeo Therapeutics·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
LXEO fundamentals
Lexeo Therapeutics (LXEO) released its earnings on Aug 14, 2025: revenue was 0 (YoY 0.00%), beat estimates; EPS was -0.6 (YoY +6.25%), beat estimates.
Revenue / YoY
0
0.00%
EPS / YoY
-0.6
+6.25%
Report date
Aug 14, 2025
Earnings Call
9:30 AM on Aug 11, 2025
Meeting link.EPS
Revenue
Revenue & Expenses
Key Indicators
Lexeo Therapeutics (LXEO) key financial stats and ratios, covering profitability, financial health, and leverage.
Lexeo Therapeutics (LXEO)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Lexeo Therapeutics (LXEO)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Lexeo Therapeutics (LXEO)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Lexeo Therapeutics (LXEO) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Lexeo Therapeutics (LXEO) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What guidance did Lexeo Therapeutics's management provide for the next earnings period?What is Lexeo Therapeutics's gross profit margin?What were the key takeaways from Lexeo Therapeutics’s earnings call?What factors drove the changes in Lexeo Therapeutics's revenue and profit?What is the market's earnings forecast for Lexeo Therapeutics next quarter?What is Lexeo Therapeutics's latest dividend and current dividend yield?What does Lexeo Therapeutics do and what are its main business segments?What is the revenue and EPS growth rate for Lexeo Therapeutics year over year?
